4.6 Review

Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis

Journal

NEUROTHERAPEUTICS
Volume 12, Issue 2, Pages 340-351

Publisher

SPRINGER
DOI: 10.1007/s13311-015-0340-3

Keywords

ALS; RNA; RNA binding protein; TDP43; FUS; C9orf72

Funding

  1. National Institutes of Health- National Institute for Neurological Disorders and Stroke
  2. ALS Therapy Alliance
  3. Babcox Foundation
  4. Protein Folding Diseases Initiative at the University of Michigan
  5. Department of Neurology at the University of Michigan

Ask authors/readers for more resources

The degeneration of motor neurons in amyotrophic lateral sclerosis (ALS) inevitably causes paralysis and death within a matter of years. Mounting genetic and functional evidence suggest that abnormalities in RNA processing and metabolism underlie motor neuron loss in sporadic and familial ALS. Abnormal localization and aggregation of essential RNA-binding proteins are fundamental pathological features of sporadic ALS, and mutations in genes encoding RNA processing enzymes cause familial disease. Also, expansion mutations occurring in the noncoding region of C9orf72-the most common cause of inherited ALS-result in nuclear RNA foci, underscoring the link between abnormal RNA metabolism and neurodegeneration in ALS. This review summarizes the current understanding of RNA dysfunction in ALS, and builds upon this knowledge base to identify converging mechanisms of neurodegeneration in ALS. Potential targets for therapy development are highlighted, with particular emphasis on early and conserved pathways that lead to motor neuron loss in ALS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available